GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in therapeutic investigation, largely due to its notable impact on managing conditions such as second type diabetes and obesity. New research have shown that in addition to glucose management, GLP-1 medications offer potential for heart function and